Barritault Denis
University Paris Est Creteil, France
Biography
Barritault Denis graduated in Physics, completed his PhD in Biochemistry at Paris University, Post-doctoral in Molecular Immunology at Pasteur Institute and NYU as NIH Fogarty Fellow. He joined INSERM unit in Paris as Developmental Biologist. He made the first description and patents of FGF extracted from retina in 1979 and 1982 as skin and cornea healing agent. He became Full Professor and Head of Research Institute in Cell and Tissue Regeneration. He invented the RGTA matrix therapy technology and illustrated the healing potential of RGTA in many tissue lesion models. Now, as President of OTR3 and Emeritus Professor, he succeeded to bring RGTA to clinics in several products. He is still active in research and is co-author in over 200 publications and 30 patents.